Review article · 2019 · Open access

Induced pluripotent stem cells, a giant leap for mankind therapeutic applications

José Bragança, João A. Lopes, Leonardo Mendes-Silva, João Miguel Almeida Santos

World Journal of Stem Cells, 11(7), 421–430 · Published 25 July 2019 · DOI 10.4252/wjsc.v11.i7.421

Open PDFView at the publisherCite this paper

In brief

“Induced pluripotent stem cells, a giant leap for mankind therapeutic applications” is a 2019 review article by José Bragança and 3 co-authors, published in World Journal of Stem Cells. OpenAlex counts 78 citations as of 21 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at World Journal of Stem Cells.

Citations
78
Most cited in
2020 (18)
Field-weighted impact
0.96
References
64
Authors
4

Abstract

Induced pluripotent stem cells (iPSC) technology has propelled the field of stem cells biology, providing new cells to explore the molecular mechanisms of pluripotency, cancer biology and aging. A major advantage of human iPSC, compared to the pluripotent embryonic stem cells, is that they can be generated from virtually any embryonic or adult somatic cell type without destruction of human blastocysts. In addition, iPSC can be generated from somatic cells harvested from normal individuals or patients, and used as a cellular tool to unravel mechanisms of human development and to model diseases in a manner not possible before. Besides these fundamental aspects of human biology and physiology that are revealed using iPSC or iPSC-derived cells, these cells hold an immense potential for cell-based therapies, and for the discovery of new or personalized pharmacological treatments for many disorders. Here, we review some of the current challenges and concerns about iPSC technology. We introduce the potential held by iPSC for research and development of novel health-related applications. We briefly present the efforts made by the scientific and clinical communities to create the necessary guidelines and regulations to achieve the highest quality standards in the procedures for iPSC generation, characterization and long-term preservation. Finally, we present some of the audacious and pioneer clinical trials in progress with iPSC-derived cells.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Bragança, J., Lopes, J. A., Mendes-Silva, L., & Santos, J. M. A. (2019). Induced pluripotent stem cells, a giant leap for mankind therapeutic applications. World Journal of Stem Cells, 11(7), 421–430. https://doi.org/10.4252/wjsc.v11.i7.421

MLA 9

Bragança, José, et al. “Induced pluripotent stem cells, a giant leap for mankind therapeutic applications.” World Journal of Stem Cells, vol. 11, no. 7, 2019, pp. 421–430. https://doi.org/10.4252/wjsc.v11.i7.421.

Chicago

Bragança, José, João A. Lopes, Leonardo Mendes-Silva, and João Miguel Almeida Santos. 2019. “Induced pluripotent stem cells, a giant leap for mankind therapeutic applications.” World Journal of Stem Cells 11 (7): 421–430. https://doi.org/10.4252/wjsc.v11.i7.421.

Harvard

Bragança, J. et al. (2019) ‘Induced pluripotent stem cells, a giant leap for mankind therapeutic applications’, World Journal of Stem Cells, 11(7), pp. 421–430. doi:10.4252/wjsc.v11.i7.421.

IEEE

J. Bragança, J. A. Lopes, L. Mendes-Silva, and J. M. A. Santos, “Induced pluripotent stem cells, a giant leap for mankind therapeutic applications,” World Journal of Stem Cells, vol. 11, no. 7, pp. 421–430, 2019, doi: 10.4252/wjsc.v11.i7.421.

BibTeX

@article{braganca2019induced,
  title     = {{Induced pluripotent stem cells, a giant leap for mankind therapeutic applications}},
  author    = {Bragança, José and Lopes, João A. and Mendes-Silva, Leonardo and Santos, João Miguel Almeida},
  journal   = {World Journal of Stem Cells},
  year      = {2019},
  volume    = {11},
  number    = {7},
  pages     = {421--430},
  doi       = {10.4252/wjsc.v11.i7.421},
  url       = {https://doi.org/10.4252/wjsc.v11.i7.421}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201811
201911
20201818
20211818
20221212
20231515
202488
202533
202622

Its field-weighted citation impact is 0.96: it has been cited 0.96 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • induced pluripotent stem cells
  • cell therapy
  • iPSC-derived cells
  • disease modeling
  • pluripotency

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Bragança, J., Lopes, J. A., Mendes-Silva, L., & Santos, J. M. A. (2019). Induced pluripotent stem cells, a giant leap for mankind therapeutic applications. World Journal of Stem Cells, 11(7), 421–430. https://doi.org/10.4252/wjsc.v11.i7.421

How many times has this paper been cited?

78 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at World Journal of Stem Cells: sign in and open the PDF from this page.

Who wrote this paper?

José Bragança, João A. Lopes, Leonardo Mendes-Silva, João Miguel Almeida Santos.

What is the DOI of this paper?

10.4252/wjsc.v11.i7.421, permanently at https://doi.org/10.4252/wjsc.v11.i7.421. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.